Alapis and RBS step on warpath over Ђ60m factoring deal
Alapis, the Greek pharmaceutical company, continues to fight to get back 60 million from Royal Bank of Scotland (RBS).
All news and features older than 7 days are subscription only. This article is from the archive. Archived articles could only be accessed with the subscription. If you are a subscriber please log in, alternatively you need to purchase a subscription to view the full content for this page.
